Fundamentals for e-Therapeutics ( etx )
Current Price: 0.09
Market Cap: 54.34m
Price / Net Assets: 1.64
Internal Rate of Return: 0%
PE10 Ratio: -7.96
Dividend Yield: 0%
Currency: £ GBP
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £0.47m | £0.48m | £0.32m | £0.46m | £0.04m | £0m | £0m | £0m | £0m | £0m | £0m |
| Revenue Growth | -2.08% | 50.00% | -30.43% | 1,050.00% | - | - | - | - | - | - | 119% |
| Profit / Loss | £-8.27m | £-8.07m | £-3.68m | £-2.35m | £-4m | £-5.36m | £-13.13m | £-8.82m | £-7.78m | £-5.04m | £-7m |
| Profit Increase/Decrease | 2.48% | 119.29% | 56.60% | -41.25% | -25.37% | -59.18% | 48.87% | 13.37% | 54.37% | - | 19% |
| Profit / Sales Ratio | - | - | - | - | - | - | - | - | - | - | 0% |
| Earnings per Share | £-0.02 | £-0.02 | £-0.01 | £-0.01 | £-0.01 | £-0.02 | £-0.05 | £-0.03 | £-0.03 | £-0.02 | £-0.02 |
| Total Debt | £1.60m | £1.78m | £0.43m | £0.29m | £0.71m | £1.02m | £1.95m | £1.16m | £1.14m | £1.00m | £1.11m |
| Net Assets | £33.04m | £27.73m | £13.88m | £4.50m | £6.80m | £10.74m | £15.98m | £28.43m | £37.02m | £44.62m | £22.27m |
| Debt / Asset Ratio | 4.62% | 6.03% | 3.00% | 6.05% | 9.45% | 8.67% | 10.88% | 3.92% | 2.99% | 2.19% | 2.19% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0.00x |